World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
129
Citations
56922
World Ranking
248
National Ranking
163

Medicine

D-Index
131
Citations
57686
World Ranking
2411
National Ranking
1364

Marinos C. Dalakas publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marinos C. Dalakas sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 608 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marinos C. Dalakas D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marinos C. Dalakas sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 129 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marinos C. Dalakas is affiliated with Thomas Jefferson University in the United States. Their research primarily focuses on the field of Medicine, with a notable emphasis on Neurology. Within this broad area, their work spans several subfields including Neurology, Infectious Diseases, Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, and Epidemiology.

Dalakas has contributed extensively to topics related to Peripheral Neuropathies and Disorders, Autoimmune Neurological Disorders and Treatments, Myasthenia Gravis and Thymoma, Multiple Sclerosis Research Studies, Long-Term Effects of COVID-19, Inflammatory Myopathies and Dermatomyositis, and COVID-19 Clinical Research Studies.

The scientist has published in a variety of academic journals, with frequent contributions to:

  • Neurology Neuroimmunology & Neuroinflammation
  • Neurology
  • Therapeutic Advances in Neurological Disorders
  • Neurotherapeutics
  • Nature Reviews Neurology

Recent notable papers by Dalakas include:

  • Complement in neurological disorders and emerging complement-targeted therapeutics, 2020, Nature Reviews Neurology
  • Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease, 2020, Neurology Neuroimmunology & Neuroinflammation
  • The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors, 2021, Therapeutic Advances in Neurological Disorders

Dalakas collaborates frequently with other researchers. Key coauthors include:

  • Harry Alexopoulos
  • Maria Anagnostouli
  • Panos Stathopoulos
  • Maria Gontika
  • George P. Chrousos

Best Publications

  • Polymyositis and Dermatomyositis

    Marinos C Dalakas;Reinhard Hohlfeld

  • Polymyositis, Dermatomyositis, and Inclusion-Body Myositis

    Marinos C. Dalakas

  • A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis

    Marinos C. Dalakas;Isabel Illa;James M. Dambrosia;Shawke A. Soueidan

  • A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

    Lori A. Love;Richard L. Leff;David D. Fraser;Ira N. Targoff

  • Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy

    Marinos C. Dalakas;Isabel Illa;G.H. Pezeshkpour;Joseph P. Laukaitis

  • Mitochondrial toxicity of antiviral drugs.

    William Lewis;Marinos C. Dalakas

  • Inflammatory Muscle Diseases

    Marinos C. Dalakas

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    G K Bertsias;J P A Ioannidis;M Aringer;E Bollen

  • Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

    Richard A C Hughes;Peter Donofrio;Vera Bril;Marinos C Dalakas

  • Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

    Karl Poetter;He Jiang;Shahin Hassanzadeh;Stephen R. Master

  • Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy

    R Hughes;Peter Van den Bergh;S Bensa;H Willison

  • Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

    E. Arnaudo;S. Shanske;S. DiMauro;E.A. Schon

  • Missense mutations in desmin associated with familial cardiac and skeletal myopathy

    Lev G. Goldfarb;Kye-Yoon Park;Larisa Cervenáková;Larisa Cervenáková;Svetlana Gorokhova

  • Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene

    Marinos C. Dalakas;Kye-Yoon Park;Cristina Semino-Mora;Hee Suk Lee

  • High-dose intravenous immune globulin for stiff-person syndrome.

    Marinos C. Dalakas;Mavis Fujii;Mian Li;Bashar Lutfi

  • A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms.

    Marinos C. Dalakas;Gregory Elder;Mark Hallett;John Ravits

  • Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors

    Elizabeth A. Sekul;Edward J. Cupler;Marinos C. Dalakas

  • High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.

    M Basta;Marinos C Dalakas

  • Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases

    Marinos C. Dalakas

  • The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome.

    Marinos C. Dalakas;Mavis Fujii;Mian Li;Beverly McElroy

  • Inclusion body myositis and myopathies.

    Kumaraswamy Sivakumar;Marinos C. Dalakas

Frequent Co-Authors

Lev G. Goldfarb
Lev G. Goldfarb National Institutes of Health
Norman Latov
Norman Latov Cornell University
Athanasios G. Tzioufas
Athanasios G. Tzioufas National and Kapodistrian University of Athens
Richard H. Quarles
Richard H. Quarles National Institutes of Health
Richard A. C. Hughes
Richard A. C. Hughes University College London
William A. Gahl
William A. Gahl National Institutes of Health
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Mark Hallett
Mark Hallett National Institutes of Health
Hugh J. Willison
Hugh J. Willison University of Glasgow
Frederick W. Miller
Frederick W. Miller National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring allied healthcare fields can open diverse career opportunities. Nursing programs, particularly those focusing on specialized care, are a popular choice for many students. If you’re considering a nursing career, exploring the easiest LPN programs to get into can be a great way to start your healthcare journey with less barrier to entry.

For advanced practice, becoming a Family Nurse Practitioner (FNP) allows for expanded roles in patient care, often overlapping with immunological health management. You can find accessible pathways to this career through the easiest FNP program options online.

Specializing even further, psychiatric nurse practitioners play critical roles in mental health, an area biologically linked to immunology. To ensure excellent clinical experience, consider enrolling in one of the top psychiatric mental health nurse practitioner programs online.

Cost is a common concern, so it’s useful to check out the cheapest psych NP programs online to balance quality education with your budget.

Best Scientists Citing Marinos C. Dalakas

Trending Scientists

Recently Published Articles